Low dose (d1-5/7) oral etoposide regimen in intensively treated platinum-resistant epithelial ovarian cancer: The İzmir oncology group (IZOG) study . Annals of Medical Research, [S. l.], v. 27, n. 1, p. 0029–0033, 2021. Disponível em: http://annalsmedres.org/index.php/aomr/article/view/591. Acesso em: 4 apr. 2025.